Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1047 Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastoma

4 affiliations
  1. 11Massachusetts Institute of Technology, Cambridge, MA, USA
  2. 2Massachusetts Institute of Technology, Cambridge, MA, USA
  3. 3Brigham and Women’s Hospital, Boston, MA, USA
  4. 4Mayo Clinic, Rochester, MN, USA

Related

  1. Alternative Splicing of Homologous Recombination Genes Is Associated with Homologous Recombination Deficiency and Immunoregulatory Phenotypes in Breast Cancer
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Dynamics of cell states and alternative splicing following kidney ischemia-reperfusion injury
    Dana Markiewitz, Jacob Goldberger, Tomer Kalisky
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  3. Integration of gene expression and alternative splicing enhances IGHV mutation status and survival risk prediction in chronic lymphocytic leukemia
    Lei Yu, Ruidong Li, Meiling Jin +5
    Scientific ReportsPeer-reviewedCC BYFull textHuman geneticsDOAJ
  4. Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications
    Lucia Maria Procopciuc, Adriana Corina Hangan, Roxana Liana Lucaciu
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  5. Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface
    Johan Siewiera, Ghilas Ferrat, Nabila Jabrane-Ferrat
    Mucosal ImmunologyPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyObstetrics, gynaecology & paediatricsHAL
BibTeX
@article{cui20261047,
  title = {{1047 Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastoma}},
  author = {Yufei Cui and Aram Shajii and Michael Scott Regan and Kaitlyn Bootz and Heidi M Temple and Jennifer Gantchev and Dani Burgenske and Nathalie Agar and Jann Sarkaria and Terry Burns and Forest M White},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1047},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1047},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1047 Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastoma
AU  - Yufei Cui
AU  - Aram Shajii
AU  - Michael Scott Regan
AU  - Kaitlyn Bootz
AU  - Heidi M Temple
AU  - Jennifer Gantchev
AU  - Dani Burgenske
AU  - Nathalie Agar
AU  - Jann Sarkaria
AU  - Terry Burns
AU  - Forest M White
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1047
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1047
SN  - 2051-1426
ER  -